6 completed, 1 recruiting, 1 unknown. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Completed 6, Recruiting 1, Unknown 1 |
Follow Adverse Drug Event: new trials by email Literature Review of Adverse Drug Event trials Research Report on Adverse Drug Event
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery Patients Requiring Mechanical Ventilation Remimazolam Besylate, Dexmedetomidine Hydrochloride - Effect of Drug, Adverse Drug Event | Phase 4 | Recruiting | Beijing Shijitan Hospital, Capital Medical University | 306 | 2025-01-20 | 2026-06-16 |
| Oliceridine in Patients With Acute Burn Injuries Oliceridine, Historical opioid use - Acute Pain, Burns | Phase 4 | Completed | University of Tennessee | 31 | 2023-04-01 | 2023-10-26 |
| Simultaneous mRNA COVID-19 and IIV4 Vaccination Study mRNA COVID-19, IIV4, Placebo (saline) - Quality of Life, Injection Site Reaction | Phase 4 | Completed | Duke University | 348 | 2021-10-04 | 2024-03-19 |
| Simultaneous RZV and aIIV4 Vaccination FLUAD® Quadrivalent, Fluzone® High-Dose Quadrivalent, SHINGRIX® - Pain, Quality of Life | Phase 4 | Completed | Duke University | 267 | 2021-09-21 | 2024-07-11 |
| Research on Human Insulin rDNA Safety and Efficacy in Patients With Type 2 Diabetes Mellitus Insulin - Adverse Drug Event, Effect of Drug | Phase 4 | Completed | Getz Pharma | 238 | 2021-01-01 | 2023-02-06 |
| Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Atropine sulfate and epinephrine, Topical cyclopentolate and phenylephrine - Cataract, Mydriasis | Phase 4 | Unknown | Dar El Oyoun Hospital | 40 | 2018-09-28 | 2018-10-09 |
| FLUAD® vs. Fluzone® High-Dose Study FLUAD®, Fluzone® High-Dose - Pain, Quality of Life | Phase 4 | Completed | Duke University | 757 | 2017-08-28 | 2021-03-30 |
| PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment ERIBULIN MESYLATE - Metastatic Breast Cancer, Toxicity | Phase 4 | Completed | Oncologia Medica dell'Ospedale Fatebenefratelli | 200 | 2014-05-01 | 2021-03-04 |
Drug-Related Side Effects and Adverse Reactions (8) · Influenza, Human (3) · Injection Site Reaction (3) · Pain (2) · Acute Pain (1) · Breast Neoplasms (1) · Burns (1) · COVID-19 (1) · Cataract (1) · Critical Illness (1) · Diabetes Mellitus, Type 2 (1) · Insulin Resistance (1) · Mydriasis (1) · Neurotoxicity Syndromes (1) · Postoperative Nausea and Vomiting (1)
Chemically-Induced Disorders (8) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Respiratory Tract Diseases (4) · Extravasation of Diagnostic and Therapeutic Materials (3) · Infections (3) · Neurologic Manifestations (3) · Orthomyxoviridae Infections (3) · RNA Virus Infections (3) · Respiratory Tract Infections (3) · Signs and Symptoms (3) · Virus Diseases (3) · Breast Diseases (1) · Coronaviridae Infections (1) · Coronavirus Infections (1)
Influenza Vaccines (2) · ((3-methoxythiophen-2-yl)methyl)((2-(9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine (1) · 2019-nCoV Vaccine mRNA-1273 (1) · Atropine (1) · Cyclopentolate (1) · Dexmedetomidine (1) · Epinephrine (1) · Insulin (1) · Phenylephrine (1) · Sodium Chloride (1) · eribulin (1) · fluad vaccine (1)
Duke University (3) · Beijing Shijitan Hospital, Capital Medical University (1) · Dar El Oyoun Hospital (1) · Getz Pharma (1) · Oncologia Medica dell'Ospedale Fatebenefratelli (1) · University of Tennessee (1)
United States (4) · China (1) · Egypt (1) · Italy (1) · Pakistan (1)
Kenneth Schmader, MD (2) · Elizabeth Barnett, MD (1) · Elizabeth Schlaudecker, MD, MPH (1) · Emmanuel B Walter, MD, MPH (1) · Giovanna Damia, PHD (1) · Jianxin Zhou, doctor (1) · Karen R Broder, MD (1) · Kawsar Talaat, MD (1) · Theresa Harrington, MD (1)
PMID 33443580, PMID 36307826, PMID 37393237, PMID 37781954, PMID 39446325, PMID 39504023, PMID 41380398